维普中文期刊产品整合服务
20篇 您的检索式:作者名="Kontou P"
    题名 作者 年代 出处 被引量
1Pharmacokinetics of moxifloxacin and high-dose levofloxacin in severe lower respiratory tract infections显示文摘KONTOU P MANIKA K CHATZIKA K 2013Int J Antimicrob Agents2013,42,3:1
2Hydrogen production by ethanol steam reforming over a commercial Pd/C- Al2O3 catalyst 显示文摘Goula M A Kontou S K Tsiakaras P E 2004Applied Catalysis B: Environmental2004,49,:1
3Fitting multi-dimensional amotivation into the self-determination theory nomological network: Application in school physical education显示文摘VLACHOPOULOS S P KATARTZI E S KONTOU M G 2013Measurement in Physical Education and Exercise Science2013,17,:1
4Pharmacokinetics of moxifloxacin and high-dose levofloxacin in severe lower respir- atory tract infections显示文摘Kontou P Manika K Chatzika K 2013Int J Antimicrob Agents2013,42,3:1
5Interrelation between moisture absorption, mechanical behavior and extent of the boundary interphase in particulate composites 显示文摘Theocaris P S Papanicolaou G C Kontou E A 1983Journal of Applied Polymer Science1983,28,10:1
6Moxifloxacin pharmacokinetics and pleural fluid penetration in patients with pleural effusion显示文摘Chatzika K Manika K Kontou P 2014Antimicrob Agents Chemother2014,58,3:1
7Hydrogen production by ethanol steam reforming over a commercial Pd/γ-Al2O3 catalyst显示文摘 KONTOU S K TSIAKARAS P E 2004Appl Catal B2004,49,2:1
8Skeletal Growth Factor Involvement in the Regulation of Fracture Healing Process显示文摘GS Themistocleous SE Kontou P Lembessis 2003In vivo2003,17,:1
9Pharmacokinetics of ciprofloxacin and its penetration into bronchial secretions of mechanically ventilated patients with chronic obstructive pulmonary disease显示文摘Kontou P Chatzika K Pitsiou G 2011Antimicrob Agents Chemother2011,55,9:1
10The role of nanofillers on the degradation behavior of poly lactic acid显示文摘Kontou E Georgiopoulos P Niaounakis M 2012Polymer Composites2012,33,2:1
11Pharmacokinetics of moxifloxacin and high-dose levofloxacin in severe lower respiratory tract infections显示文摘Kontou P Manika K Chatzika K 2013Inter J Antimicrob Agents2013,42,3:1
12Pharmacokinetics of moxi- floxacin and high-dose levofloxacin in severe lower respiratory tract infections显示文摘Kontou P Manika K Chatzika K 2013Int J Antimicrob Agents2013,42,3:1
13Validation of the infectious diseases society of America/American thoracic society criteria to predict severe community - acquired pneumonia caused by streptococcus pneumoniae 显示文摘KONTOU P KUTI JL NICOLAU DP 2009American Journal of Emergency Medicine2009,27,8:1
14Pharmacokinetics of moxi- floxacin and high-dose levofloxacin in severe lower respiratory tract in- fections 显示文摘Kontou P Manika K Chatzika K 2013Int J Antimicrob Agents2013,42,3:1
15Pharmacokineties of moxifloxaein and high-dose levofloxacin in severe lower re- spiratory tract infeetions显示文摘Kontou P Manika K Chatzika K 2013Int J Antimierob Agents2013,42,3:1
16Pharmacokinetics of moxifloxacin and high-dose levofloxacin in severe lower respiratory tract infections显示文摘Kontou P Manika K Chatzika K 2013Inter J Antimicr Agents2013,42,3:1
17Bi- and tri- metallic Pt-based anode catalysts for direct ethanol fuel cells 显示文摘ZHOU W J LI W Z SONG S Q ZHOU Z H JIANG L H SUN G Q XIN Q POULIANITIS K KONTOU S TSIAKARAS P 2004J Power Sources2004,131,12:1
18Pharmacokinetics of moxifloxacin and high-dose levofloxacin in severe lower respiratory tract infections显示文摘Kontou P Manika K Chatzika K 2013Int J Antimicrob Agents2013,42,3:1
19Moxifloxacin phar- macokinetics and pleural fluid penetration in patients with pleural effusion显示文摘Chatzika K Manika K Kontou P 2014Antimicrob Agents Chemother2014,58,3:1
20Pharmacokinetics of moxifloxacin and high-dose levofloxacin in severe lower respiratory tract infections 显示文摘Kontou P Manika K Chatzika K 2013Int J Antimicrob Agents2013,42,3:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费